Sharp John P 4
4 · PhaseBio Pharmaceuticals Inc · Filed Aug 22, 2019
Insider Transaction Report
Form 4
Sharp John P
CFO and Secretary
Transactions
- Exercise/Conversion
Employee Stock Option (right to buy)
2019-08-21−5,000→ 4,038 totalExercise: $1.44Exp: 2027-04-21→ Common Stock (5,000 underlying) - Exercise/Conversion
Common Stock
2019-08-21$1.69/sh+10,000$16,900→ 30,000 total - Exercise/Conversion
Common Stock
2019-08-21$1.44/sh+5,000$7,200→ 35,000 total - Exercise/Conversion
Employee Stock Option (right to buy)
2019-08-21−10,000→ 110,582 totalExercise: $1.69Exp: 2026-05-12→ Common Stock (10,000 underlying)
Footnotes (2)
- [F1]25% of the shares subject to the option shall vest on April 11, 2017, the first anniversary of the Vesting Commencement Date, and the remainder of the shares subject to the option shall vest in equal monthly installments over 36 months on the same day of the month as the Vesting Commencement Date, subject to the reporting person's continued service through each such date. The vesting schedule for this option was incorrectly reported in a prior filing due to a clerical error.
- [F2]The shares subject to the option shall vest in equal monthly installments over 48 months from March 1, 2017, subject to the reporting person's continued service through each such date.